Navigation Links
Researchers find organic pollutants not factor in turtle tumor disease
Date:7/15/2014

For nearly four decades, scientists have suspected that persistent organic pollutants (POPs) contributed to a green turtle's susceptibility to the virus that causes fibropapilomatosis (FP), a disease that forms large benign tumors that can inhibit the animal's sight, mobility and feeding ability. In a new study,* researchers from the Hollings Marine Laboratory (HML), a government-university partner facility in Charleston, S.C., and from university and federal collaborators in Hawaii demonstrated POPs are not, in fact, a co-factor linked to the increasing number of green sea turtles afflicted with FP.

POPs are a large group of man-made chemicals that, as their name indicates, persist in the environment. They also spread great distances through air and water, accumulate in human and animal tissues, increase in concentration up food chains, and may have carcinogenic and neurodevelopmental effects. POPs include banned substances such as DDT and toxaphenes, once used as pesticides; polychlorinated biphenyls (PCBs), once used as insulating fluids; and polybrominated diphenyl ethers (PDBEs), still used as flame retardants. Two previous studies attempting to link POPs and FP were unable to rule out the impact of the pollutants on the disease.

"We wanted to do a thorough study looking at a large, statistically valid population of turtles and using methods that could detect even tiny levels of POPs in their tissues," says National Institute of Standards and Technology (NIST) research biologist Jennifer Keller, lead author on the paper appearing in the journal Environmental Science and Technology.

Keller and her colleagues collected turtle blood samples at four locations across Hawaii, each one having a different prevalence of FPnone, low, moderate and highin the marine turtle population residing there. "We analyzed the plasma for 164 different organic compounds to see if POP concentrations increased with increasing prevalence of FP," Keller says. "We also looked at the levels of halogenated phenols, chemicals which can come from either man-made [POP] sources or naturally from the green turtle's main food source, marine algae."

The researchers discovered that increasing POP concentrations did not correspond with a like rise in the numbers of FP tumors observed. "Our findings show that POPs are not the trigger for FP, so we can eliminate these pollutants from future studies trying to explain why the disease is more common in certain areas or why its prevalence is changing with time," Keller says.

As for halogenated phenols, the team found that the sampled turtles did have detectable concentrations of the compounds. "While it's a novel discovery for sea turtles, we believe that these phenols are likely from the turtle's diet of algae rather than man-made POPs," Keller explains.


'/>"/>

Contact: Michael E. Newman
michael.newman@nist.gov
301-975-3025
National Institute of Standards and Technology (NIST)
Source:Eurekalert  

Related biology news :

1. Largest International Meeting for the Study of Reproductive Biology Attracts Researchers from 36 Countries in Grand Rapids, Michigan
2. Little too late: Researchers identify disease that may have plagued 700-year-old skeleton
3. Researchers declassify dinosaurs as being the great-great-grandparents of birds
4. IPCC must consider alternate policy views, researchers say
5. Science and cookies: Researchers tap into citizen science to shed light on ant diversity
6. Researchers receive $12.6 million NIH grant to study genetics of Alzheimers
7. Researchers uncover new knowledge about our intestines
8. SDSC assists researchers in novel wildlife tracking project
9. Deforestation remedies can have unintended consequences, UF researchers say
10. Using geometry, researchers coax human embryonic stem cells to organize themselves
11. NIH-funded researchers extend liver preservation for transplantation
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Researchers find organic pollutants not factor in turtle tumor disease
(Date:2/10/2017)... 10, 2017 Research and Markets ... "Personalized Medicine - Scientific and Commercial Aspects" to their ... ... is integrated with therapy for selection of treatment as well ... and prevention of disease in modern medicine. Biochip/microarray technologies and ...
(Date:2/8/2017)... Mass., Feb. 7, 2017  Aware, Inc. (NASDAQ: ... today reported financial results for its quarter and year ended ... quarter of 2016 was $3.9 million compared to $6.9 million ... fourth quarter of 2016 was $0.6 million compared to $2.6 ... the fourth quarter of 2016 was $0.5 million, or $0.02 ...
(Date:2/8/2017)... -- Report Highlights The global biosurgery market ... in 2016 at a compound annual growth rate (CAGR) ... - An overview of the global market for biosurgery. ... 2015 and 2016, and projections of compound annual growth ... on the basis of product type, source, application, and ...
Breaking Biology News(10 mins):
(Date:2/23/2017)... Feb. 23, 2017  In Atlanta, it seems everyone has ... culture intertwine to create an expressive and dynamic community unlike ... energy and contribute to it. With their ... Fairies seeks to carry on that tradition with a ... Atlanta salon is the newest of 13 nationwide ...
(Date:2/23/2017)... ... February 23, 2017 , ... David ... Inventors Recognition Reception at Purdue Research Park of West Lafayette, Indiana. ... recognition of outstanding contributions to, and success with, commercializing discoveries from Purdue research. ...
(Date:2/23/2017)... SAN FRANCISCO , Feb. 23, 2017   ... Beyond Type 1, a not-for-profit advocacy and education group ... a grant from Beyond Type 1 to support ViaCyte,s ... and other insulin-requiring diabetes.  For more ... cell-derived cell replacement therapies with a focus on the ...
(Date:2/22/2017)... , Feb. 22, 2017  PrimeVax Immuno-Oncology, Inc. announced ... presenting at the Annual Biocom Global Life Science Partnering ... at 11:15 AM, at the Torrey Pines Lodge, in ... the organizers at Biocom who have chosen our company, ... of biotechnology companies, investors, and clinical researchers," said Mr. ...
Breaking Biology Technology: